10.09 22:19 | dpa-AFX: *DANAHER CORP. (DHR) DECLARES QUARTERLY DIVIDEND OF $ 0.27, RECORD DATE 9/27/2024 |
10.09 22:16 | dpa-AFX: *DANAHER DECLARES QUARTERLY DIVIDEND OF $0.27/SHARE, PAYABLE OCT. 25/ RECORD SEPT. 27 |
24.07 10:04 | dpa-AFX: *BARCLAYS RAISES DANAHER PRICE TARGET TO 285 (270) USD - 'EQUAL WEIGHT' |
24.07 10:04 | dpa-AFX: *BARCLAYS HEBT ZIEL FÜR DANAHER AUF 285 (270) USD - 'EQUAL WEIGHT' |
23.07 15:43 | dpa-AFX: *DANAHER +6,8% - SPRINGEN DEUTLICH ÜBER 50-TAGE-LINIE |
23.07 13:49 | dpa-AFX: Pre-market Movers: FEIM, TUSK, MIRA, CLRB, PII. |
23.07 13:13 | dpa-AFX: AKTIEN-FLASH: Danaher mildert jüngsten Kurseinbruch von Sartorius etwas ab |
23.07 13:04 | dpa-AFX: Danaher Q2 24 Earnings Conference Call At 8:00 AM ET |
23.07 13:02 | dpa-AFX: *DANAHER NACH ZAHLEN VORBÖRSLICH FAST +7% - KLEINER SQUEEZE IN SARTORIUS + STEDIM |
23.07 12:08 | dpa-AFX: *DANAHER EXPECTS FY NON-GAAP CORE REVENUE TO BE DOWN LOW-SINGLE DIGITS YEAR-OVER-YEAR |
23.07 12:08 | dpa-AFX: *DANAHER EXPECTS Q3 NON-GAAP CORE REVENUE TO BE DOWN LOW-SINGLE DIGITS YEAR-OVER-YEAR |
23.07 12:07 | dpa-AFX: *DANAHER Q2 NON-GAAP ADJ. EPS $1.72 VS $1.73 PRIOR YEAR |
23.07 12:06 | dpa-AFX: *DANAHER Q2 NET EARNINGS $907 MLN OR $1.22/SHR VS $1.11 BLN OR $1.24/SHR PRIOR YEAR |
23.07 12:03 | dpa-AFX: Danaher Corp. Reveals Decline In Q2 Profit |
23.07 12:02 | dpa-AFX: *DANAHER Q2 REVENUES DECREASE 3.0% Y-O-Y TO $5.7 BLN AND NON-GAAP CORE REVENUE DECREASE 3.5% |
17.07 13:31 | dpa-AFX: *DANAHER ANNOUNCES TWO NEW CENTERS OF INNOVATION IN DIAGNOSTICS TO TRANSFORM PRECISION MEDICINE DEVELOPMENT DANAHER |
09.07 09:02 | dpa-AFX: *BECKMAN COULTER UNVEILS INTEGRATED CHEMISTRY AND IMMUNOASSAY ANALYZER |
19.06 13:40 | dpa-AFX: *DANAHER APPOINTS JULIE SAWYER MONTGOMERY TO EVP FOR DIAGNOSTICS, EFFECTIVE AS OF JULY 1, 2024 |
05.06 13:01 | dpa-AFX: *DANAHER APPOINTS MARTIN STUMPE TO NEW ROLE OF CHIEF DATA & ARTIFICIAL INTELLIGENCE OFFICER |
09.05 13:19 | dpa-AFX: *DANAHER LAUNCHES COLLABORATION WITH JOHNS HOPKINS UNIVERSITY TO IMPROVE NEUROLOGICAL DIAGNOSIS |
|